Perrigo
PRGO
#5360
Rank
$1.50 B
Marketcap
$10.88
Share price
-2.16%
Change (1 day)
-58.76%
Change (1 year)

P/E ratio for Perrigo (PRGO)

P/E ratio as of May 2026 (TTM): -0.8489

According to Perrigo's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.848855. At the end of 2025 the company had a P/E ratio of -1.35.

P/E ratio history for Perrigo from 2001 to 2026

PE ratio at the end of each year

Year P/E ratio Change
2025-1.35-93.19%
2024-19.9-93.35%
2023-299

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
United Therapeutics
UTHR
19.3-2,370.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-0.0001-99.98%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
2.97-450.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
-49.2 5,697.14%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.